tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE
US Market

Fate Therapeutics (FATE) Income Statement

Compare
1,161 Followers

Fate Therapeutics Income Statement

Last quarter (Q3 2024), Fate Therapeutics's total revenue was $3.07M, an increase of 58.13% from the same quarter last year. In Q3, Fate Therapeutics's net income was $-47.68M. See Fate Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 63.53M$ 96.30M$ 55.85M$ 31.43M$ 10.68M
Gross Profit
$ -98.16M$ 82.54M$ 50.00M$ -94.19M$ -77.09M
Operating Expenses
$ 254.04M$ 404.69M$ 272.84M$ 159.52M$ 111.41M
Depreciation and Amortization
$ 18.28M$ 13.76M$ 5.85M$ 3.09M$ 2.19M
EBITDA
$ -172.23M$ -294.63M$ -211.14M$ -125.00M$ -94.20M
Operating Income
$ -190.51M$ -308.39M$ -216.99M$ -128.09M$ -100.73M
Other Income/Expenses
$ 29.58M$ 26.66M$ 4.84M$ -45.30M$ 2.58M
Pretax Income
$ -160.93M$ -281.72M$ -212.15M$ -173.39M$ -98.15M
Net Income
$ -160.93M$ -255.06M$ -206.30M$ -170.30M$ -97.71M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.64$ -2.63$ -2.18$ -2.07$ -1.43
Diluted EPS
$ -1.64$ -2.63$ -2.18$ -2.07$ -1.43
Weighted Average Shares Outstanding
98.41M 96.83M 94.75M 82.39M 68.19M
Weighted Average Shares Outstanding (Diluted)
98.41M 96.83M 94.75M 82.39M 68.19M
Currency in USD

Fate Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis